TB treatment: latest news

TB treatment resources

  • Tuberculosis

    Tuberculosis (TB) is an infection that usually affects the lungs.It can be very serious, particularly for people with HIV who have a low CD4 count.TB can be...

    From: Factsheets

    Information level Level 2
  • Treatment for TB and HIV

    If tuberculosis (TB) is making you ill and you also have HIV, then you usually need to take treatment for both TB and HIV.You can...

    From: The basics

    Information level Level 1
  • HATIP #39, 5th January 2005

    Risk of TB doubles in first year of HIV infection http://www.aidsmap.com/en/news/95D84EF4-94DE-41FD-B20C-3247321E70DA.asp?hp=1 The risk of developing tuberculosis doubles within the first year of testing HIV positive, according to...

    From: HIV & AIDS treatment in practice

    Information level Level 4

TB treatment features

TB treatment in your own words

TB treatment news from aidsmap

More news

TB treatment news selected from other sources

  • Kenya to roll out child-friendly tuberculosis medicines nationwide

    TB medicines specially adapted for children have been available since 2015, as a result of the UNITAID-funded STEP-TB project. In 2013 UNITAID committed 16.72 million dollars towards the implementation of the STEP-TB project, which brought together TB Alliance, and other partners to develop the first formulations of TB medicines that meets dosage guidelines set by the World Health Organization (WHO) in 2010.

    27 September 2016 | UNITAID
  • WHO launches Target Regimen Profiles for TB treatment

    Aimed at the pharmaceutical industry, research institutions, product development partnerships and donors, the new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.

    08 September 2016 | World Health Organization
  • TB Can Persist in Lungs Despite Treatment

    The findings show that TB bacteria may persist in the lungs even after patients have finished treatment and are free of clinical symptoms. Although it is unclear how this might affect the risk of disease relapse, the study results underscore the need for new diagnostic methods and improved TB treatment strategies, according to the researchers.

    07 September 2016 | National Institute of Allergy and Infectious Diseases
  • Patients with TB and HIV should receive prompt coordinated treatment for both conditions

    Tuberculosis is a leading killer of people with HIV, and providing therapy for both illnesses simultaneously saves lives - according to new guidelines on the treatment of drug-susceptible TB developed jointly by the American Thoracic Society, Centers for Disease Control and Prevention and Infectious Diseases Society of America. Treatment of TB in the presence of HIV infection is one of several special situations addressed in the new guidelines.

    15 August 2016 | Eurekalert Inf Dis
  • Daily TB Treatment Better Than Intermittent

    Patients diagnosed with tuberculosis as well as HIV do better in combating tuberculosis with an intensified daily regimen rather than intermittent therapy that delivers less medicine, researchers reported here.

    22 July 2016 | MedPage Today HIV/AIDS
  • “Towards Ending the Neglect?” DNDi Releases Update on its Paediatric HIV Programme

    The Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treat­ment regimen for infants and young chil­dren.

    17 July 2016 | DNDi
  • Leave no one behind: Stop TB Partnership launches seven key population briefs

    The Stop TB Partnership today launched a series of briefs on TB key populations recognizing that reaching everyone with services, diagnostics, treatment and care is essential to ending the TB epidemic.

    17 May 2016 | Stop TB Partnership
  • In Côte d’Ivoire, two million TB drugs financed by The Global Fund sold in street markets

    In Côte d’Ivoire, the Nouvelle Pharmacie de la Santé Publique (NPSP), the facility responsible for receiving, warehousing and distributing medicines, and the Programme National de Lutte contre la Tuberculose (PNLT), a principal recipient, were responsible for a massive diversion of TB drugs financed by The Global Fund.

    19 April 2016 | Global Fund Observer
  • Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

    Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Médecins Sans Frontières (MSF).

    24 March 2016 | Médecins Sans Frontières
  • Statins cut tuberculosis treatment time in mice

    In a study using mice, the Johns Hopkins University School of Medicine infectious disease experts have added to evidence that statin drugs -- known primarily for their cholesterol-lowering effects -- can significantly reduce the time it takes to clear tuberculosis infection.

    16 March 2016 | EurekAlert (press release)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close